Literature DB >> 25777788

Characterization of all possible single-nucleotide change caused amino acid substitutions in the kinase domain of Bruton tyrosine kinase.

Jouni Väliaho1, Imrul Faisal1, Csaba Ortutay1,2, C I Edvard Smith3, Mauno Vihinen1,4,5.   

Abstract

Knowledge about features distinguishing deleterious and neutral variations is crucial for interpretation of novel variants. Bruton tyrosine kinase (BTK) contains the highest number of unique disease-causing variations among the human protein kinases, still it is just 10% of all the possible single-nucleotide substitution-caused amino acid variations (SNAVs). In the BTK kinase domain (BTK-KD) can appear altogether 1,495 SNAVs. We investigated them all with bioinformatic and protein structure analysis methods. Most disease-causing variations affect conserved and buried residues disturbing protein stability. Minority of exposed residues is conserved, but strongly tied to pathogenicity. Sixty-seven percent of variations are predicted to be harmful. In 39% of the residues, all the variants are likely harmful, whereas in 10% of sites, all the substitutions are tolerated. Results indicate the importance of the entire kinase domain, involvement in numerous interactions, and intricate functional regulation by conformational change. These results can be extended to other protein kinases and organisms.
© 2015 WILEY PERIODICALS, INC.

Entities:  

Keywords:  BTK; Bruton tyrosine kinase; X-linked agammaglobulinemia; XLA; kinase domain; mutation; protein structure

Mesh:

Substances:

Year:  2015        PMID: 25777788     DOI: 10.1002/humu.22791

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  17 in total

1.  Identification and characterization of tyrosine kinases in anole lizard indicate the conserved tyrosine kinase repertoire in vertebrates.

Authors:  Ake Liu; Funan He; Xun Gu
Journal:  Mol Genet Genomics       Date:  2017-08-17       Impact factor: 3.291

2.  PON-P and PON-P2 predictor performance in CAGI challenges: Lessons learned.

Authors:  Abhishek Niroula; Mauno Vihinen
Journal:  Hum Mutat       Date:  2017-05-02       Impact factor: 4.878

3.  Targeted RNAseq Improves Clinical Diagnosis of Very Early-Onset Pediatric Immune Dysregulation.

Authors:  Kiera Berger; Dalia Arafat; Shanmuganathan Chandrakasan; Scott B Snapper; Greg Gibson
Journal:  J Pers Med       Date:  2022-06-01

Review 4.  Next Generation Sequencing Data Analysis in Primary Immunodeficiency Disorders - Future Directions.

Authors:  Mingyan Fang; Hassan Abolhassani; Che Kang Lim; Jianguo Zhang; Lennart Hammarström
Journal:  J Clin Immunol       Date:  2016-03-18       Impact factor: 8.317

5.  Identification of biochemically neutral positions in liver pyruvate kinase.

Authors:  Tyler A Martin; Tiffany Wu; Qingling Tang; Larissa L Dougherty; Daniel J Parente; Liskin Swint-Kruse; Aron W Fenton
Journal:  Proteins       Date:  2020-06-27

6.  KinMutRF: a random forest classifier of sequence variants in the human protein kinase superfamily.

Authors:  Tirso Pons; Miguel Vazquez; María Luisa Matey-Hernandez; Søren Brunak; Alfonso Valencia; Jose Mg Izarzugaza
Journal:  BMC Genomics       Date:  2016-06-23       Impact factor: 3.969

7.  Primary Immunodeficiencies in India: Molecular Diagnosis and the Role of Next-Generation Sequencing.

Authors:  Arun Kumar Arunachalam; Madhavi Maddali; Fouzia N Aboobacker; Anu Korula; Biju George; Vikram Mathews; Eunice Sindhuvi Edison
Journal:  J Clin Immunol       Date:  2020-11-23       Impact factor: 8.317

8.  Harmful somatic amino acid substitutions affect key pathways in cancers.

Authors:  Abhishek Niroula; Mauno Vihinen
Journal:  BMC Med Genomics       Date:  2015-08-19       Impact factor: 3.063

9.  Computational Analysis of the Binding Specificities of PH Domains.

Authors:  Zhi Jiang; Zhongjie Liang; Bairong Shen; Guang Hu
Journal:  Biomed Res Int       Date:  2015-12-31       Impact factor: 3.411

10.  Substitution scanning identifies a novel, catalytically active ibrutinib-resistant BTK cysteine 481 to threonine (C481T) variant.

Authors:  A Hamasy; Q Wang; K E M Blomberg; D K Mohammad; L Yu; M Vihinen; A Berglöf; C I E Smith
Journal:  Leukemia       Date:  2016-05-25       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.